Medtronic (NYSE: MDT) is a leading medical device company that aims to simplify patients' everyday lives. And with a broad presence that spans 150 countries, treating more than 70 health conditions, Medtronic has the potential to be a great healthcare investment to buy and hold.

Unfortunately, the company has battled multiple headwinds in recent times, which has led to uninspiring financials and a disappointing stock performance. In the past three years, shares of Medtronic have fallen by 24%. Can the next three years be better ones for the stock, or are there fundamental problems with Medtronic's business?

A big problem with Medtronic recently has been that the top line hasn't shown much growth. In its most recent fiscal year (ended April 30, 2023), the company's revenue totaled $31.2 billion and trailed the $31.7 billion that it reported a year earlier.

Continue reading

Source Fool.com